Clinical Trials Logo

Clinical Trial Summary

Background: Chronic kidney disease is associated with comorbid conditions that result in physical impairments. Objectives: Investigate the impact of chronic kidney disease (CKD) on postural stability in children compared with age matched typically developing children using Human Assessment Computer (HUMAC) balance system. Design: An observational design (cross-sectional study). Settings: The assessment procedures were conducted at the Nephrology Unit, Zagazig University Hospitals. Participants: Seventy-five children, age ranged from 8 to 15 years represented three groups of equal numbers; control group (typically developed), non-dialysis (stage 3 and 4) and hemodialysis group. Outcome measures: The HUMAC balance system was used to assess the limits of stability, center of pressure and sensory organization and balance.


Clinical Trial Description

Methods Study design This study is an observational cross-sectional design (prospective database study). Participants and setting Participants included children with CKD extracted from a data set of 731 individuals with CKD diagnoses, who receive regular medical follow-up/hemodialysis at Nephrology Unit, Zagazig University Hospitals. The study was conducted from January 2018 to January 2020 in accordance with the Declaration of Helsinki (Code of Ethics of the World Medical Association). The study protocol was approved by the Ethical committee of the Faculty of Physical Therapy, Cairo University, Egypt (No.P.T.REC/012/002169). Children's par-ticipation was authorized by a signed written consent form with parent's/legal guardian's acceptance for participation before starting the study procedures. Participants Fifty eligible volunteer children with CKD were recruited from Nephrology Unit, Zagazig University Hospitals to be enrolled in this study and allocated into either hemodialysis (on hemodialysis) or non-dialysis group (children at stage 3 and 4). Eligible criteria: - Medically diagnosed with CKD (regardless of medical history), - Age ranged from eight to fifteen years, - Both genders Participants were excluded if they had: - Communication problems such as intellectual disability, autism, Down syndrome, or cerebral palsy, - Significant visual or hearing problems, - Any neurological and/or musculoskeletal disorders which influence postural stability, - Chronic cardiovascular or pulmonary disorders. Twenty-five volunteer typically developed age matched group were enrolled as control group. Basic demographic and clinical information Demographics and physical characteristics (age, sex, weight, height) and clinical data (renal function test, recent hematology and blood chemistry counts, co-morbidity, and medication) were recorded from medical reports to confirm diagnosis. Study power and sample size Sample size was predestined before conducting the study by G*POWER statistical software (Franz Faul, Universitat Kiel, Germany; version 3.1.9.2) [F tests- ANOVA: Fixed effects, one-way, α=0.05, β=0.2, and large effect size] with the number of groups=3, giving a total number of 66 participants to be recruited in this study. 2.5. Outcome measures The Human Assessment Computer (HUMAC) Balance System, primarily being part of a video game appliance (Wii Balance Board), is a distinct technology used in assessment and rehabilitation of postural control. It is an affordable, portable and prevalent obtainable force plate provides the patient and tester with visual feedback as well as numerical data. The system displays several reporting options with objective datum providing clinicians with comprehensive case progression which is used for baseline and follow-up analysis with eight programs to choose from (HUMAC balance, 2017; Blosch et al., 2019). The HUMAC-type technology has been found to detect more imbalances than traditional tests (Merchant-Borna et al., 2017). In the current study limits of stability, COP and the Clinical Test of Sensory Organization and Balance (CTSIB) were assessed. Each child in the three study groups performed three trials and the mean value was estimated for each test. 2.5.1. Limits of Stability test: Limits of stability are known as the furthest distance a subject is capable to shift his/her COP in different directions whilst keeping the configuration of the BOS and adjust the body position. This commonly requires the use of a force plate that records COP movement and a visual feedback that serves to maximize COP displacement in certain directions (Lemay et al., 2014). During this test, the participant is instructed to shift the round cursor on the screen (the COP) to the highlighted target. As he/she remains in the target for the hold time, this target point is deactivated and should move between the center targets to each surrounding target in a random order. A count-up timer displays the total test time. He/she must return to the center target after each outer target. The test was conducted at two levels 4 and 6. At level 4; this is considered as simple test compared with level 6; the distance between center targets to each surrounding target is relatively small. On the other hand, at level 6 the distance between center targets to each surrounding target is larger. 2.5.2. Center of pressure test This test is used to measure the variation in a subject's COP and displays his/her Right/Left and Anterior/Posterior weight distribution. In the current study, the COP test variables recorded were the stability score and path length. - Stability test: It measures the participant's ability to stabilize his/her balance at locations around their neutral position. Results are reported as the percent of time a subject holds his COP in each of the eight flashing targets in clockwise order (right/left and anterior/posterior weight distribution). These targets are eight specific points in which the current target flashes green when the participant is on-target and flashes yellow when he is off-target. The HUMAC system provides a counts-down of the hold time to inform the participant when he/she should move to the next target. In addition, the system provides variety of levels based on the distance from the center to the farthest target. - Path length: The COP path length represents the COP displacement in which lower values indicate better performance (Ju-Hyeong et al., 2020). 2.5.3. Clinical Test of Sensory Organization and Balance: It is sometimes referred as the Romberg or Foam and Dome test. It is used to test how a participant's vestibular, somatosensory and visual systems integrate in the conditions of open and closed eyes compared to a normal population. The CTSIB protocol typically uses four conditions including eyes closed soft surface (ECSS); eyes closed firm surface (ECFS); eyes open soft surface (EOSS); Eye open soft surface (EOSS) and eyes open firm surface (EOFS). The participant was instructed to stand in a neutral position with the arms at body sides. Each participant went through a series of the four tests, which were each 30 seconds long. As participants completed the test, the board monitored their COG to determine their stability and path length. The requirements of the assessment were clearly demonstrated to all children. The assessment procedures were administered following the HUMAC Balance System manual detailed instructions. All participants performed three trials of each test, each lasting 30 seconds to determine the stability score and path length. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04411927
Study type Observational
Source Cairo University
Contact
Status Completed
Phase
Start date January 1, 2018
Completion date January 20, 2020

See also
  Status Clinical Trial Phase
Recruiting NCT06386172 - Electronic Decision-support System to Improve Detection and Care of Patients With Chronic Kidney Disease in Stockholm N/A
Recruiting NCT04910867 - APOL1 Genetic Testing Program for Living Donors N/A
Completed NCT03434145 - Changes of Ocular Structures After Hemodialysis in Patients With Chronic Kidney Diseases N/A
Recruiting NCT04984226 - Sodium Bicarbonate and Mitochondrial Energetics in Persons With CKD Phase 2
Active, not recruiting NCT05887817 - Effects of Finerenone on Vascular Stiffness and Cardiorenal Biomarkers in T2D and CKD (FIVE-STAR) Phase 4
Recruiting NCT05318196 - Molecular Prediction of Development, Progression or Complications of Kidney, Immune or Transplantation-related Diseases
Terminated NCT05022329 - COVID-19 Vaccine Boosters in Patients With CKD Phase 2/Phase 3
Not yet recruiting NCT04925661 - HEC53856 Phase Ib Study in Patients With Non-dialysis Renal Anemia Phase 1
Recruiting NCT04961164 - Resistant Starch Prebiotic Effects in Chronic Kidney Disease N/A
Completed NCT05015647 - Low Protein Diet in CKD Patients at Risk of Malnutrition N/A
Completed NCT03426787 - Helping Empower Liver and Kidney Patients N/A
Recruiting NCT06094231 - Treating Patients With Renal Impairment and Altered Glucose MetAbolism With TherapeutIc Carbohydrate Restriction and Sglt2-Inhibiton - a Pilot Study N/A
Completed NCT04363554 - The Kidneys Ability to Concentrate and Dilute Urine in Patients With Autosomal Dominant Polycystic Kidney Disease N/A
Recruiting NCT04831021 - Pre- or Per-dialytic Physical Exercise : a Cardioprotective Role? N/A
Terminated NCT04877847 - Multi-Center Trial Utilizing Low Frequency Ultrasound in the Prevention of Post-Contrast Acute Kidney Injury N/A
Recruiting NCT04422652 - Combination of Novel Therapies for CKD Comorbid Depression Phase 2
Completed NCT05055362 - Effect a Honey, Spice-blended Baked Good Has on Salivary Inflammation Markers in Adults: a Pilot Study N/A
Not yet recruiting NCT06330480 - Check@Home: General Population Screening for Early Detection of Atrial Fibrillation and Chronic Kidney Disease N/A
Recruiting NCT03176862 - Left Ventricular Fibrosis in Chronic Kidney Disease N/A
Terminated NCT02539680 - Intestinal Phosphate Transporter Expression in CKD Patients N/A